Stay updated on Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial
Sign up to get notified when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.

Latest updates to the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page
- Check4 days agoChange DetectedThe Revision tag on the history page was updated from v3.6.4 to v3.6.5, signaling a new version of the record UI.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe revision label at the bottom of the study history page was updated from v3.6.3 to v3.6.4, indicating a new version of the record-keeping interface.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedNew release note 'Revision: v3.6.3' was added to the study record history, while the prior 'Revision: v3.6.2' entry was removed. This reflects a site-wide update being logged in the history and does not alter the study data or records.SummaryDifference0.1%

- Check47 days agoChange DetectedThe footer now displays Revision: v3.6.2, replacing Revision: v3.6.0, indicating an update to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check62 days agoChange DetectedNew navigation links 'Check who can join' and 'Find Contact Information' were added to the page, improving quick access to enrollment and contact details. The release tag now shows 'Revision: v3.6.0' and the previous 'Revision: v3.5.5' tag has been removed.SummaryDifference0.4%

- Check69 days agoChange DetectedRevision: v3.5.5 replaces the previous revision label (v3.5.4) on the study history page, signaling a new version of the page's revision history.SummaryDifference0.1%

Stay in the know with updates to Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.